All news
Neutral impactOrders & Deals

Mono Pharmacare Limited — Disclosure under SEBI Takeover Regulations

NSE 4d ago·14 Jul 2026, 8:45 am

Mono Pharmacare Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Stocks in this story

Mono Pharmacare10.60 0.00%

Key takeaways

  • Concerns Mono Pharmacare (MONOPHARMA).
  • Category: Orders & Deals.

Why it matters

A routine update for Mono Pharmacare. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.

More Company news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.

Mono Pharmacare Limited — Disclosure under SEBI Takeover Regulations | Mono Pharmacare (MONOPHARMA)